<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Tuberculosis (TB) is an infectious and contagious disease caused by Mycobacterium tuberculosis, and it mainly affects the lungs. As Romania has consistently ranked first in the European Union (EU) in terms of the incidence and prevalence of TB in the past years, this paper aims to bring to the attention of physicians the new therapeutic regimens and ways to approach patients with multidrug resistant TB and extended resistance.</p>
</abstract>

Tuberculosis (TB) is an infectious and contagious disease caused by Mycobacterium tuberculosis, and it mainly affects the lungs. As Romania has consistently ranked first in the European Union (EU) in terms of the incidence and prevalence of TB in the past years, this paper aims to bring to the attention of physicians the new therapeutic regimens and ways to approach patients with multidrug resistant TB and extended resistance.

New therapeutic approach for multidrug resistant pulmonary tuberculosis

“Carol Davila” University of Medicine and Pharmacy

The Multidisciplinary Research Department

Pneumologia

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

{"article-title":"New therapeutic approach for multidrug resistant pulmonary tuberculosis"}

Tuberculosis (TB) is an infectious and contagious disease caused by Mycobacterium tuberculosis, and it mainly affects the lungs. As Romania has consistently...

New therapeutic approach for multidrug resistant pulmonary tuberculosis

Online veröffentlicht: 21. Okt. 2022

Seitenbereich: 106 - 110

DOI: https://doi.org/10.2478/pneum-2022-0024

Schlüsselwörter
drug resistant tuberculosis, new therapeutic regimen

© 2022 Justina Antonela Dragomir et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

New therapeutic approach for multidrug resistant pulmonary tuberculosis

Online veröffentlicht: 21. Okt. 2022

Seitenbereich: 106 - 110

DOI: https://doi.org/10.2478/pneum-2022-0024

Schlüsselwörterdrug resistant tuberculosis, new therapeutic regimen

© 2022 Justina Antonela Dragomir et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Schlüsselwörter
drug resistant tuberculosis, new therapeutic regimen